Are ketogenic diets promising for Alzheimer's disease? A translational review

被引:46
|
作者
Lilamand, Matthieu [1 ,2 ,3 ,4 ]
Porte, Baptiste [1 ,2 ]
Cognat, Emmanuel [1 ,2 ]
Hugon, Jacques [1 ,2 ]
Mouton-Liger, Francois [1 ,2 ]
Paquet, Claire [1 ,2 ]
机构
[1] Univ Paris, INSERM, U1144, Optimisat Therapeut Neuropsychopharmacol, Paris, France
[2] Nord Univ Paris, Lariboisiere Hosp, APHP, CMRR Paris Nord Ile France,Ctr Neurol Cognit, 200 Rue Faubourg, F-75010 Paris, France
[3] APHP Nord Univ Paris, Dept Geriatr, Bichat, Bretonneau Hospitals, F-75018 Paris, France
[4] Nord Univ Paris, Bichat & Bretonneau Hosp, APHP, Dept Geriatr, F-75018 Paris, France
关键词
Ketogenic diet; Alzheimer's disease; Brain metabolism; Animal models; MOUSE MODEL; COGNITIVE IMPAIRMENT; BETA-HYDROXYBUTYRATE; KETONE ESTER; SUPPLEMENTATION; METABOLISM; MITOCHONDRIA; MEMORY;
D O I
10.1186/s13195-020-00615-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Brain amyloid deposition and neurofibrillary tangles in Alzheimer's disease (AD) are associated with complex neuroinflammatory reactions such as microglial activation and cytokine production. Glucose metabolism is closely related to neuroinflammation. Ketogenic diets (KDs) include a high amount of fat, low carbohydrate and medium-chain triglyceride (MCT) intake. KDs lead to the production of ketone bodies to fuel the brain, in the absence of glucose. These nutritional interventions are validated treatments of pharmacoresistant epilepsy, consequently leading to a better intellectual development in epileptic children. In neurodegenerative diseases and cognitive decline, potential benefits of KD were previously pointed out, but the published evidence remains scarce. The main objective of this review was to critically examine the evidence regarding KD or MCT intake effects both in AD and ageing animal models and in humans. Main body We conducted a review based on a systematic search of interventional trials published from January 2000 to March 2019 found on MEDLINE and Cochrane databases. Overall, 11 animal and 11 human studies were included in the present review. In preclinical studies, this review revealed an improvement of cognition and motor function in AD mouse model and ageing animals. However, the KD and ketone supplementation were also associated with significant weight loss. In human studies, most of the published articles showed a significant improvement of cognitive outcomes (global cognition, memory and executive functions) with ketone supplementation or KD, regardless of the severity of cognitive impairments previously detected. Both interventions seemed acceptable and efficient to achieve ketosis. Conclusion The KD or MCT intake might be promising ways to alter cognitive symptoms in AD, especially at the prodromal stage of the disease. The need for efficient disease-modifying strategies suggests to pursue further KD interventional studies to assess the efficacy, the adherence to this diet and the potential adverse effects of these nutritional approaches.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Is Ketogenic Diet Therapy a Remedy for Alzheimer’s Disease or Mild Cognitive Impairments?: A Narrative Review of Randomized Controlled Trials
    H. Şimşek
    A. Uçar
    Advances in Gerontology, 2022, 12 : 200 - 208
  • [22] Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review)
    Cai, Zhiyou
    MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1533 - 1541
  • [23] Impact of diet and exercise on mitochondrial quality and mitophagy in Alzheimer's disease
    Pradeepkiran, Jangampalli Adi
    Islam, Md. Ariful
    Sehar, Ujala
    Reddy, Arubala P.
    Vijayan, Murali
    Reddy, P. Hemachandra
    AGEING RESEARCH REVIEWS, 2025, 108
  • [24] Translational Research in Genomics of Alzheimer's Disease: A Review of Current Practice and Future Perspectives
    Mihaescu, Raluca
    Detmar, Symone B.
    Cornel, Martina C.
    van der Flier, Wiesje M.
    Heutink, Peter
    Hol, Elly M.
    Rikkert, Marcel G. M. Olde
    van Duijn, Cornelia M.
    Janssens, A. Cecile J. W.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (04) : 967 - 980
  • [25] Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer's Disease
    Pinto, Alessandro
    Bonucci, Alessio
    Maggi, Elisa
    Corsi, Mariangela
    Businaro, Rita
    ANTIOXIDANTS, 2018, 7 (05)
  • [26] Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine
    Zeng, Qiang
    Siu, Wingsum
    Li, Limin
    Jin, Yu
    Liang, Shaoyu
    Cao, Meiqun
    Ma, Min
    Wu, Zhengzhi
    EXPERIMENTAL GERONTOLOGY, 2019, 119 : 100 - 110
  • [27] The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease
    Cellai, Lucrezia
    Carvalho, Kevin
    Faivre, Emilie
    Deleau, Aude
    Vieau, Didier
    Buee, Luc
    Blum, David
    Meriaux, Celine
    Gomez-Murcia, Victoria
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [28] Ketone Bodies Metabolism and Alzheimer's Disease
    Shi Le
    Long Jian-Gang
    Liu Jian-Kang
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2015, 42 (04) : 323 - 328
  • [29] Probiotics for Alzheimer's Disease: A Systematic Review
    Naomi, Ruth
    Embong, Hashim
    Othman, Fezah
    Ghazi, Hasanain Faisal
    Maruthey, Nithiyah
    Bahari, Hasnah
    NUTRIENTS, 2022, 14 (01)
  • [30] The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease
    Broom, Gina M.
    Shaw, Ian C.
    Rucklidge, Julia J.
    NUTRITION, 2019, 60 : 118 - 121